Application of Alistipes putredinis bacteria in preparation of medicine for preventing and treating inflammatory bowel disease
A technology for inflammatory bowel disease and drugs, applied in the field of preparation of drugs for the prevention and treatment of inflammatory bowel disease, to achieve the effect of reducing disease activity index, reducing intestinal mucosal damage and inflammation, and reducing symptoms
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0020] The inflammatory bowel disease of the present invention preferably includes Crohn's disease. The active ingredient of the medicament of the present invention preferably includes the supplemented Alistipes putredinis bacterial liquid. The preparation method of the supplemented Alistipes putredinis bacterial liquid of the present invention preferably includes: taking the Alistipes putredinis bacterial liquid activated and cultured in a medium for 3 days, collecting the bacterial cells after centrifugation, and resuspending with anaerobic PBS to an OD value of 1.
[0021] The preparation method of the Alistipes putredinis bacterial liquid of the present invention preferably includes inoculating the dry powder of Alistipes putredinis into a medium for 3d activation culture, and the medium is based on a BHI (brain-heartinfusion broth, brain-heart infusion) medium. The medium also includes 5 μg / mL heme and 0.5 μg / mL vitamin K1. The preparation method of the culture medium of...
Embodiment 1
[0028] A. putredinis abundance is significantly decreased in the gut of CD patients
[0029] Metagenomics analysis of stool samples from 30 pre-treatment CD patients and 30 healthy controls was entrusted to Zhongke New Life.
[0030] The result is as figure 1 shown, the abundance of A. putredinis was significantly reduced in CD patients compared with healthy controls ( figure 1 in A-B). At the same time, the Gram stain of A. putredinis was negative ( figure 1 middle C). Scanning electron microscope observation showed that A. putredinis was a typical rod-shaped bacteria ( figure 1 middle D).
Embodiment 2
[0032] A. putredinis inhibits intestinal inflammation in DSS colitis mice
[0033] like figure 2 The experimental design shown in middle A: C57BL / 6 mouse DSS colitis model (Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal intestinal was used) inflammation.NatProtoc.2017Jul;12(7):1295-1309), A.putredinis was administered by gavage (take 1×10 9 CFU / mL bacterial solution was centrifuged at 4000 rpm for 10 min at 4°C to collect the bacterial pellet, then resuspended with anaerobic PBS to an OD value of 1, and administered 200 μL / gavage).
[0034] The results are shown in Tables 1 to 5 and figure 2As shown, DSS colitis mice showed different degrees of weight loss, and A. putredinis inhibited the weight loss, and the weight loss rate from the 4th day was lower than that of DSS colitis mice ( figure 2 in B-C). In addition, A. putredinis significantly down-regulated the symptoms o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com